BAX

Executive Summary for Baxter International Investors

Health Care sector company Baxter International posted a 2.91% performance today, while the S&P 500 returned 0.66%.

13 analysts are following Baxter International and have set target prices ranging from $40.0 to $63.2 per share. On average, they have given the company a rating of buy. At today's prices, BAX is trading -19.08% away from its average analyst target price of $48.48 per share.

Over the last year, BAX shares have gone down by -50.29%, which represents a difference of -37.08% when compared to the S&P 500. The stock's 52 week high is $79.03 per share and its 52 week low is $37.35. Although Baxter International's average free cash flow over the last four years has been $1,187,200,000.0, they have been decreasing at an average rate of -10.08%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations (k) Capital Expenditures (k) Free Cash Flow (k) YoY Growth
2022-12-31 $1,211,000 $679,000 $532,000 -64.03%
2021-12-31 $2,222,000 $743,000 $1,479,000 27.61%
2020-12-31 $1,868,000 $709,000 $1,159,000 -17.68%
2019-12-31 $2,104,000 $696,000 $1,408,000 3.68%
2018-12-31 $2,017,000 $659,000 $1,358,000 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS